Back
Kamada Vs. NovoCure Industry Stock Comparison
Buy
73
KMDA
Kamada
Last Price:
$6.44
Seasonality Move:
0.83%
Sell
49
NVCR
NovoCure
Last Price:
$30.18
Seasonality Move:
-3.69%
Sell
49
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
-
NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVCR Stock Price Chart
KMDA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.1 | Buy |
Relative Strength Index (14 RSI): | 69.5 | Buy |
Chaikin Money Flow: | 17543 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.82 - 6.16) | Buy |
Bollinger Bands (100): | (5.33 - 5.97) | Buy |
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.94 | Buy |
Relative Strength Index (14 RSI): | 58.79 | Buy |
Chaikin Money Flow: | -60501 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.36 - 32.64) | Buy |
Bollinger Bands (100): | (14.38 - 25.86) | Buy |
KMDA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.11 | Buy |
20-day SMA: | 6 | Buy |
50-day SMA: | 5.9 | Buy |
200-day SMA: | 5.53 | Buy |
8-day EMA: | 6.15 | Buy |
20-day EMA: | 6.03 | Buy |
50-day EMA: | 5.88 | Buy |
200-day EMA: | 5.61 | Buy |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.52 | Sell |
20-day SMA: | 30.41 | Sell |
50-day SMA: | 23.25 | Buy |
200-day SMA: | 18.89 | Buy |
8-day EMA: | 30.36 | Sell |
20-day EMA: | 29.22 | Buy |
50-day EMA: | 25.18 | Buy |
200-day EMA: | 21.21 | Buy |
Kamada Earnings Growth & KMDA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.03 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and an increase next year of $0.06 per share.
Kamada Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovoCure Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |